BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23001603)

  • 1. Hunting osteoporosis susceptibility genes: bigger is better but diverse is also welcome.
    Rivadeneira F
    Endocrine; 2013 Feb; 43(1):6-7. PubMed ID: 23001603
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women.
    Deng YH; Zhao L; Zhang MJ; Pan CM; Zhao SX; Zhao HY; Sun LH; Tao B; Song HD; Wang WQ; Ning G; Liu JM
    Endocrine; 2013 Feb; 43(1):127-35. PubMed ID: 22798246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MEF2C gene-microdeletion 5q14.3 dilemma and three axioms for molecular syndromology.
    Wilson GN
    Am J Med Genet A; 2013 Apr; 161A(4):916-7. PubMed ID: 23495102
    [No Abstract]   [Full Text] [Related]  

  • 4. Late-onset gain of skills and peculiar jugular pit in an 11-year-old girl with 5q14.3 microdeletion including MEF2C.
    Berland S; Houge G
    Clin Dysmorphol; 2010 Oct; 19(4):222-224. PubMed ID: 20729728
    [No Abstract]   [Full Text] [Related]  

  • 5. An intellectually disabled patient with the 5q14.3q15 microdeletion syndrome associated with an apparently de novo t(2;5)(q13;q14).
    Toral-López J; Buentello-Volante B; Balderas-Minor MM; Amezcua-Herrera C; Valdes-Miranda JM; González-Huerta LM; Gudiño M; Cuevas-Covarrubias SA; Zenteno JC
    Am J Med Genet A; 2012 Apr; 158A(4):942-6. PubMed ID: 22419405
    [No Abstract]   [Full Text] [Related]  

  • 6. Vertebrate paralogous MEF2 genes: origin, conservation, and evolution.
    Wu W; de Folter S; Shen X; Zhang W; Tao S
    PLoS One; 2011 Mar; 6(3):e17334. PubMed ID: 21394201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Properties comparing and evolutionary analysis of MEF2 of Homo sapiens based on bioinformatic methods].
    Guo XJ
    Yi Chuan; 2011 Sep; 33(9):975-81. PubMed ID: 21951798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.
    Maiti D; Xu Z; Duh EJ
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3640-8. PubMed ID: 18450586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New polymorphisms in human MEF2C gene as potential modifier of hypertrophic cardiomyopathy.
    Alonso-Montes C; Naves-Diaz M; Fernandez-Martin JL; Rodriguez-Reguero J; Moris C; Coto E; Cannata-Andia JB; Rodriguez I
    Mol Biol Rep; 2012 Sep; 39(9):8777-85. PubMed ID: 22718505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of MEF2A-DNA interface by rigid body docking: a tool for fast estimation of protein mutational effects on DNA binding.
    Fanelli F; Ferrari S
    J Struct Biol; 2006 Mar; 153(3):278-83. PubMed ID: 16427316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of autophagy and Parkinson's disease: the MEF2D link.
    Yang Q; Mao Z
    Apoptosis; 2010 Nov; 15(11):1410-4. PubMed ID: 20165919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enrichment of conserved synaptic activity-responsive element in neuronal genes predicts a coordinated response of MEF2, CREB and SRF.
    Rodríguez-Tornos FM; San Aniceto I; Cubelos B; Nieto M
    PLoS One; 2013; 8(1):e53848. PubMed ID: 23382855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory polymorphism in transcription factor KLF5 at the MEF2 element alters the response to angiotensin II and is associated with human hypertension.
    Oishi Y; Manabe I; Imai Y; Hara K; Horikoshi M; Fujiu K; Tanaka T; Aizawa T; Kadowaki T; Nagai R
    FASEB J; 2010 Jun; 24(6):1780-8. PubMed ID: 20086047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of salt-inducible kinase 1 in the activation of MEF2-dependent transcription by BDNF.
    Finsterwald C; Carrard A; Martin JL
    PLoS One; 2013; 8(1):e54545. PubMed ID: 23349925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEF2A sequence variants in Turkish population.
    Gulec S; Ruchan Akar A; Akar N
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):465-7. PubMed ID: 18160598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation.
    Grégoire S; Tremblay AM; Xiao L; Yang Q; Ma K; Nie J; Mao Z; Wu Z; Giguère V; Yang XJ
    J Biol Chem; 2006 Feb; 281(7):4423-33. PubMed ID: 16356933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1alpha represses MEF2-dependent gene expression.
    Perry RL; Yang C; Soora N; Salma J; Marback M; Naghibi L; Ilyas H; Chan J; Gordon JW; McDermott JC
    Mol Cell Biol; 2009 Jun; 29(12):3355-66. PubMed ID: 19364819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in MEF2 and NFAT transcriptional pathways according to human heart failure aetiology.
    Cortés R; Rivera M; Roselló-Lletí E; Martínez-Dolz L; Almenar L; Azorín I; Lago F; González-Juanatey JR; Portolés M
    PLoS One; 2012; 7(2):e30915. PubMed ID: 22363514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid receptor and myocyte enhancer factor 2 cooperate to regulate the expression of c-JUN in a neuronal context.
    Speksnijder N; Christensen KV; Didriksen M; De Kloet ER; Datson NA
    J Mol Neurosci; 2012 Sep; 48(1):209-18. PubMed ID: 22622902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolutionary genetic analyses of MEF2C gene: implications for learning and memory in Homo sapiens.
    Kalmady SV; Venkatasubramanian G; Arasappa R; Rao NP
    Asian J Psychiatr; 2013 Feb; 6(1):56-9. PubMed ID: 23380319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.